Table 1.
Patient data in the study and control groups
| Study group (n = 70) | Control group (n = 173) | p value | |
|---|---|---|---|
|
Patient data | |||
| Age [years] |
69.2 ± 9.9 |
67.1 ± 9.8 |
0.14 |
| Sex [m / f] |
23 / 47 |
69 / 104 |
0.31 |
| (% male) |
32.9 |
39.9 |
|
| Weight [kg] |
73.4 ± 11.4 |
76.7 ± 14 |
0.08 |
| Height [m] |
1.66 ± 0.09 |
1.68 ± 0.1 |
0.12 |
| BMI [kg / m2] |
26.2 ± 3.9 |
26.7 ± 4.4 |
0.42 |
| HHS preop. |
35.5 ± 14.3 |
39.4 ± 15.7 |
0.07 |
|
Femoral defects (I – III Paprosky classification) [intraoperative findings] | |||
| Type I [n] (%) |
4 (5.7) |
12 (6.9) |
0.73 |
| Type II A [n] (%) |
20 (28.6) |
55 (31.8) |
0.62 |
| Type II B [n] (%) |
15 (21.4) |
33 (19.1) |
0.68 |
| Type II C [n] (%) |
12 (17.1) |
35 (20.2) |
0.58 |
| Typ III [n] (%) |
19 (27.1) |
38 (22) |
0.39 |
|
MRP-TITAN stem diameter | |||
| 13 / 14 mm [n] (%) |
10 (14.3) |
22 (12.7) |
0.74 |
| 15 / 16 mm [n] (%) |
21 (30) |
56 (32.4) |
0.72 |
| 17 / 18 mm [n] (%) |
24 (34.3) |
59 (34.1) |
0.98 |
| 19 / 20 mm [n] (%) |
13 (18.6) |
35 (20.2) |
0.77 |
| ≥ 21 mm [n] (%) | 2 (2.9) | 1 (0.6) | 0.15 |